Variant report
Variant | nsv1049069 |
---|---|
Chromosome Location | chr13:66647914-66681970 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17252389 | chr13:66647914-66647915 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs183868051 | chr13:66647924-66647925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs139207034 | chr13:66647937-66647938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs142514129 | chr13:66647971-66647972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs73512949 | chr13:66647983-66647984 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs61338297 | chr13:66648005-66648006 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs527844415 | chr13:66648007-66648008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs546730340 | chr13:66648021-66648022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs566603166 | chr13:66648033-66648034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs538723959 | chr13:66648113-66648114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188450279 | chr13:66648128-66648129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs73201726 | chr13:66648145-66648146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs34393825 | chr13:66648184-66648185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs191816163 | chr13:66648210-66648211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544237645 | chr13:66648226-66648227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs537754760 | chr13:66648242-66648243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575719135 | chr13:66648252-66648253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs554810015 | chr13:66648253-66648254 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs574307879 | chr13:66648254-66648255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs113603825 | chr13:66648311-66648312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs9571535 | chr13:66648331-66648332 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs184428503 | chr13:66648349-66648350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs115771859 | chr13:66648350-66648351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs111799082 | chr13:66648391-66648392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs75948564 | chr13:66648409-66648410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs576336884 | chr13:66648432-66648433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs542167674 | chr13:66648439-66648440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs116248181 | chr13:66648444-66648445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs375567557 | chr13:66648459-66648460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs548046683 | chr13:66648481-66648482 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs564664427 | chr13:66648564-66648565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs532452333 | chr13:66648566-66648567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs145999980 | chr13:66648593-66648594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs74841201 | chr13:66648595-66648596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs77640027 | chr13:66648613-66648614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs537813375 | chr13:66648667-66648668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs372670760 | chr13:66648670-66648671 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs375908410 | chr13:66648671-66648672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs34550393 | chr13:66648672-66648673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs201996025 | chr13:66648674-66648675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs75080008 | chr13:66648690-66648691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs9599065 | chr13:66648702-66648703 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs139941874 | chr13:66648753-66648754 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs9540627 | chr13:66648778-66648779 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs550598752 | chr13:66648826-66648827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs189356060 | chr13:66648848-66648849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs539551223 | chr13:66648856-66648857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs61956731 | chr13:66648873-66648874 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs142213297 | chr13:66648899-66648900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs78064570 | chr13:66648912-66648913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Prostate cancer | 16461572 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Intellectual disability | 21811512 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Melanoma | 20877625 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:66647600-66648600 | Enhancers | K562 | blood |
2 | chr13:66648600-66651600 | Weak transcription | K562 | blood |
3 | chr13:66651600-66651800 | Enhancers | K562 | blood |
4 | chr13:66651800-66654000 | Weak transcription | K562 | blood |
5 | chr13:66654000-66654200 | Enhancers | K562 | blood |
6 | chr13:66660800-66662600 | Enhancers | Fetal Kidney | kidney |
7 | chr13:66661400-66662000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr13:66661400-66662000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
9 | chr13:66661400-66662400 | Enhancers | Fetal Lung | lung |
10 | chr13:66666600-66667000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr13:66666800-66667000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr13:66666800-66667000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
13 | chr13:66667000-66668600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
14 | chr13:66668600-66668800 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
15 | chr13:66673200-66673600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
16 | chr13:66673200-66673800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
17 | chr13:66673400-66674000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
18 | chr13:66677000-66677400 | Enhancers | Muscle Satellite Cultured Cells | -- |